Viewing Study NCT07223567


Ignite Creation Date: 2025-12-25 @ 12:39 AM
Ignite Modification Date: 2025-12-25 @ 10:50 PM
Study NCT ID: NCT07223567
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-11-03
First Post: 2025-10-30
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Phase II Trial of Regorafenib Plus Lorigerlimab in Patients With Locally Recurrent or Regrowing pMMR/MSS Localized Rectal Cancer
Sponsor: M.D. Anderson Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module